Scientific Advisors

Teresa Allen, Ph.D., Professor of Pharmacology and Oncology, University of Alberta

Mansoor Amiji, Ph.D., Professor and Acting Chair, Department of Pharmaceutical Sciences, Northeastern University

Tom Crawford, Ph.D., Formerly, with Pharmaceutical Sciences at Pfizer

Mark E. Davis, Ph.D., Professor of Chemical Engineering, California Institute of Technology

Robert Kerbel, Ph.D., Professor of Medical Biophysics, University of Toronto

Robert Langer, Ph.D., Institute Professor and the Germeshausen Professor of Chemical and Biomedical Engineering, Massachusetts Institute of Technology.

Lawrence Reiter, Ph.D., Formerly with Medicinal Chemistry at Pfizer

Shiladitya Sengupta, Ph.D., Founder, Cerulean Pharma Inc., Assistant Professor, Harvard Medical School.

Vladimir Torchilin, Ph.D., Distinguished Professor of Pharmaceutical Sciences, Northeastern University

Bruce Zetter, Ph.D., Professor of Cancer Biology, Department of Surgery, Harvard Medical School

Medical & Clinical Advisors

Roger Cohen, M.D., Professor of Medicine and Associate Director of Clinical Research at the Abramson Cancer Center of the University of Pennsylvania

Carl June, M.D., Director, Translational Research Abramson Cancer Center at University of Pennsylvania and Professor of Pathology and Laboratory Medicine

Lee Nadler M.D., Senior Vice President, Experimental Medicine; Professor of Medicine, Harvard Medical School

Paul Nadler M.D., Managing General Partner, Nadler Pharma Associates

Daniel Von Hoff, M.D., Director Clinical Translation Research, Translational Genomics Research Institute; Clinical Professor of Medicine, University of Arizona Department of Medicine